Sentences with phrase «for product liability litigation»

Lex Machina is pleased to announce the launch of our module for Product Liability litigation.

After an exhaustive and rigorous peer - review survey comprising nearly 4 million confidential evaluations by the top attorneys in the country, Carrie Frank has been selected for inclusion in the 2012 edition of the Best Lawyers in America for Product Liability Litigation.

Two of the firm's partners were selected as «Lawyers of the Year» in their practice area: John F. Mariani in West Palm Beach for Product Liability Litigation — Defendants and Dilip Patel for Immigration Law.

Attorneys named «Best Lawyers» 2018 Tulsa Lawyers of the Year» were Mary Quinn Cooper for product liability litigation defense, Charles Greenough for banking and finance litigation, Robert J. Joyce for environmental law, and Robert E. Spoo for copyright law.

Named «Best Lawyers» 2018 «Oklahoma City Lawyers of the Year» were Timothy J. Bomhoff for product liability litigation defense, W. Chris Coleman for both securities regulation and venture capital law, Robert W. Dace for mass tort litigation / class actions defense, Elizabeth L. Dalton for franchise law, Spencer W. Haines for closely held companies and family businesses law, Henry D. Hoss for construction litigation, and Susan B. Shields for tax litigation and controversy.

The Best Lawyers in America by Woodward White, Inc. listed Banks as the «2016 Birmingham Lawyer of the Year for Product Liability Litigation Defendants»

Blackwell Burke P.A. has been included on the 2016 list with a ranking of Metropolitan Tier 1 for Products Liability Litigation — Defendant, and a Tier 2 ranking under Mass Tort Litigation / Class Actions — Defendants.

# 5 PHILADELPHIA, PENNSYLVANIA The Philadelphia Court of Common Pleas has long been known nationally center for products liability litigation.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

Second, and most important, motor vehicle litigation will move from a system where accidents are assessed based on driver negligence to a products liability system, where manufacturers bear more of the burden for failure of things such as sensors and warning systems.

Among his other distinctions, Stewart has been recognized by The Best Lawyers in America for the areas of Medical Malpractice Law (2013 — present), Personal Injury Litigation (2014 — present) and Product Liability Litigation (2016 — present).

He was recently named a 2018 Best Lawyers in America «Lawyer of the Year» in the practice area of Product Liability Litigation — Plaintiffs in West Palm Beach for his expertise.

Brendan has acted on a wide range of insurance and reinsurance matters for Australian - based and international clients, including flooding, storm, earthquake, fire and explosion events, electricity supply issues and machinery break - downs, as well as high - value class action litigation, public and product liability, and subrogation claims.

Product liability for medications that cause injury is also known as pharmaceutical litigation when the manufacturer produces a defective drug.

Prior to joining the firm, Cari represented national companies in litigation for claims involving healthcare, personal injury, contract disputes, and product liability matters.

Professional Associations Monroe County Bar Association, Member New York State Bar Association, Chairman: Torts, Insurance, and Compensation Law Section (2003 - 2004) NYSBA Automobile Liability Committee Chairman (1991 - 1995) NYSBA House of Delegates, Delegate (1999 - 2004) New York State Trial Lawyers Association Risk and Insurance Management Society (2007 - present) Council on Litigation Management (2008 - present); Chairman, Products Liability Conference (2010 - 2013) New York Editorial Board, Lawyers Cooperative Publishing Company (1993 - 1995) Defense Research Institute (2000 - present) The National Fire Protection Association, Member The American Society for Metals, Member

Steptoe's toxic tort litigation practice, which was recognized in the 2014 and 2015 editions of The Legal 500 US for providing «exceptional skill and service,» defends toxic tort, product liability and environmental claims nationwide for the chemical, petrochemical, aerospace, manufacturing, and agricultural industries.

Professional Admissions: State of New Jersey State of New York United States Supreme Court United States District Court for the District of New Jersey United States District Court for the Southern District of New York United States District Court for the Eastern District of New York United States Court of Appeals for the Second Circuit United States Court of Appeals for the Third Circuit United States Court of Appeals for the Federal Circuit Professional Activities: Appointee, District V - A Ethics Committee (Newark / Essex) Appointee, Consumer Protection Law Committee of the New Jersey State Bar Association Appointee, Business and Commercial Litigation Committee of the New Jersey State Bar Association Appointee, Franchise Law Committee of the New Jersey State Bar Association Appointee, Hudson County Civil Practice Committee Barrister, Hudson American Inn of Court Member, New Jersey Association for Justice Member, American Bar Association Member, New Jersey State Bar Association (Civil Trial Bar, Products Liability and Mass Torts, and Business and Commercial Law Sections) Member, New York Bar Association Member, Hudson County Bar Association Member, Hackensack Regional Chamber of Commerce

Our litigation and trial lawyers are experienced with the common and statutory laws involving the prospective liability of manufacturers, distributors, and sellers of products to purchasers, users, and bystanders for personal injury and property damage caused by alleged defects in those products.

Product Liability in a Legal and Regulated Market Full legalization of cannabis in California could set the stage for significant product liability litiProduct Liability in a Legal and Regulated Market Full legalization of cannabis in California could set the stage for significant product liability liLiability in a Legal and Regulated Market Full legalization of cannabis in California could set the stage for significant product liability litiproduct liability liliability litigation.

In Mixed Ruling for Food Manufacturers, the Ninth Circuit Affirms Decertification of Damages Class While Keeping Door Open for Individual Claims - Product Liability Litigation Update

But there are categories of civil litigation matters for breach of contract, fraud, insurance, product liability, and many more, and we can train a Deep Learning algorithm for any of them in an automated way.

Stephen A. LeClainche, Of Counsel at the firm, was selected for inclusion in the fields of Product Liability Litigation, Personal Injury Litigation and Mass Tort Litigation / Class Actions for the Plaintiffs practice.

Prior to joining TLR, Jami practiced commercial litigation for two years with Banowsky, Betz & Levine, P.C., in Dallas, and spent four years with Hartline, Dacus, Barger, Dreyer & Kern, L.L.P., also of Dallas, working primarily in products liability defense litigation.

Leslie M. Kroeger, a Partner at the firm, was selected for inclusion in the fields of Product Liability Litigation and Mass Tort Litigation / Class Actions for the Plaintiffs practice.

Product liability litigation is likely to include suits for physical injury arising from intoxication and suits for physical injury arising from long - term medical effects including addiction.

In a complex products liability action involving alleged PCB contamination of a state office building, the Appellate Practice Group joined forces with litigation counsel to convert a $ 60 million judgment to a defense verdict for a large, multinational company.

Our Product Liability Litigation trial lawyers have handled thousands of liability and major tort cases throughout the United States and abroad for clients from a broad spectrum of industries, iLiability Litigation trial lawyers have handled thousands of liability and major tort cases throughout the United States and abroad for clients from a broad spectrum of industries, iliability and major tort cases throughout the United States and abroad for clients from a broad spectrum of industries, including:

Before working for our firm, Patrick Montgomery worked in Birmingham as a partner for another law firm defending businesses in civil litigation covering wrongful death, catastrophic personal injury, breach of contract, product liability, automobile and trucking negligence, and premises liability.

He is honoured to have been selected as a Lexpert Ranked Lawyer for Product liability and selected by his peers for Best Lawyers 2017 for Insurance, as well as in Expert Guides in the areas of Litigation, Product Liability, Insurance and Reiliability and selected by his peers for Best Lawyers 2017 for Insurance, as well as in Expert Guides in the areas of Litigation, Product Liability, Insurance and ReiLiability, Insurance and Reinsurance.

This year he was selected in the fields of Personal Injury Litigation and Product Liability Litigation for the Plaintiffs practice.

The firm was also recognized for its strength in Product Liability Litigation by The BTI Consulting Group.

I started in the legal industry as a Database / Litigation Analyst for a large international firm in the Midwest that specialized in product liability lLitigation Analyst for a large international firm in the Midwest that specialized in product liability litigationlitigation.

Be Careful What You Wish For: Revised TSCA Process Slower Than Industry Hoped - Product Liability Litigation Update

Atlanta personal injury attorney and managing partner, Hezekiah Sistrunk, was included in the 22nd Edition of The Best Lawyers in America © for his work in Personal Injury Litigation — Plaintiffs and Product Liability — Plaintiffs.

Victory for pharmaceutical giants Pfizer in a product liability litigation about alleged cardiovascular injuries associated with testosterone replacement therapies

Following the U.S. Supreme Court's decision in Wyeth v. Levine that FDA approval does not preempt state tort liability for drug makers, state court decisions like this one will be an important battle ground in pharmaceutical companies» product liability litigation.

Prior to joining TransPerfect, Mr. Iseman managed technical discovery for complex groundwater litigation matters, including MDL 1358, In re MTBE Product Liability Litigation in which he provided technical guidance before judge Shira Slitigation matters, including MDL 1358, In re MTBE Product Liability Litigation in which he provided technical guidance before judge Shira SLitigation in which he provided technical guidance before judge Shira Scheindlin.

Wendy «leads the team's [Product Liability] insurance practice, and acted for Spire in the PIP litigation.»

Drawing on attorneys from across practice areas and offices, Weil has developed an impressive track record advising with respect to shareholder claims and demands for litigation, internal whistleblower complaints, class and collective actions brought by employees relating to pay, worker classification, and discrimination claims, product liability issues and recalls, privacy rights, intellectual property disputes (patents, trademarks, copyrights, and trade secrets), regulatory investigations commenced by the U.S. Federal Trade Commission, U.S. Department of Labor, U.S. Department of Justice, and state attorneys general, and major disputes with suppliers and competitors.

North Carolina counsel for all products liability and warranty litigation for several leading nationwide construction products manufacturers.

Named a top - ranked Tier 1 litigation firm in the U.S. for Antitrust, General Commercial, Intellectual Property, and Products Liability, and a leading litigation firm for Bankruptcy and Securities.

These factors have persuaded numerous companies to retain us as lead or coordinating counsel for their most complex product liability and mass tort litigations.

Hughes Hubbard's Product Liability and Mass Tort group is widely recognized by leading legal publications, jurists, clients and the products bar at large as a «go to» defense team for a company's most complex and challenging products litigation.

Expert development and MDL coordinating counsel for global pharmaceutical company in product liability litigation involving medication to treat gastrointestinal conditions

Mr. Sistrunk was selected by his peers for inclusion in The Best Lawyers in America 2015 for his work in the area of Personal Injury Litigation - Plaintiffs and in the 2016 and 2017 editions for his work in the areas of Personal Injury Litigation - Plaintiffs and Products Liability Litigation - Plaintiffs.

Led by co-founders and senior partners Mary Quinn Cooper and William S. Leach, ECSL specializes in commercial litigation, products liability, class actions and complex civil litigation on a regional and national level for clients ranging from small privately owned companies and government entities to Fortune 100 companies.

He has also served as National Coordinating Liability Counsel for a major international insurance company with reference to the defense of products liability claims involving thousands of individual claimants and several class actions consolidated in Federal Multi District LiLiability Counsel for a major international insurance company with reference to the defense of products liability claims involving thousands of individual claimants and several class actions consolidated in Federal Multi District Liliability claims involving thousands of individual claimants and several class actions consolidated in Federal Multi District Litigation.